Braun-Bostich & Associates’s Colgate-Palmolive CL Stock Holding History

Braun-Bostich & Associates’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,661	Closed	-$282K	–	87
2020 Q3	$282K	Sell	3,661 -4,001	-52%	-$305K	0.28%	54
2020 Q2	$561K	Hold	7,662	–	–	0.55%	28
2020 Q1	$502K	Buy	7,662 +646	+9%	+$45.6K	0.64%	29
2019 Q4	$478K	Buy	+7,016	New	+$478K	0.47%	46
2019 Q3	–	Sell	-1,727	Closed	-$124K	–	124
2019 Q2	$124K	Sell	1,727 -1,299	-43%	-$92.2K	0.13%	122
2019 Q1	$207K	Sell	3,026 -5,135	-63%	-$332K	0.22%	97
2018 Q4	$486K	Sell	8,161 -160	-2%	-$10K	0.52%	68
2018 Q3	$557K	Buy	8,321 +21	+0.3%	+$1.4K	0.54%	64
2018 Q2	$538K	Buy	8,300 +8,081	+3,690%	+$529K	0.54%	67
2018 Q1	$16K	Buy	+219	New	+$15.8K	0.01%	232

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Braun-Bostich & Associates's CL Position: Q4 2020 in Review

Braun-Bostich & Associates sold out of Colgate-Palmolive (CL) in Q4 2020, closing a stake of 3,661 shares — an estimated $282K sold.

Braun-Bostich & Associates first reported a position in CL in Q1 2018 and held it in 10 quarters. The position peaked at $561K in Q2 2020. 1,651 funds tracked by Wall St. Rank hold CL as of Q4 2020.

Braun-Bostich & Associates reported no remaining Colgate-Palmolive position as of Q4 2020 after selling out during the quarter.
Braun-Bostich & Associates sold 3,661 Colgate-Palmolive shares in Q4 2020, an estimated $282K.
Braun-Bostich & Associates first reported a position in Colgate-Palmolive in Q1 2018 and held it in 10 quarters.
Braun-Bostich & Associates's Colgate-Palmolive position peaked at $561K in Q2 2020.
1,651 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2020.

Based on Braun-Bostich & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.